A project at the ICMAB-CSIC in Barcelona is using nanomaterials to improve cancer treatment. The team, led by Gerard Tobias, has won funding from the European Research Council (ERC) to explore the commercial and societal potential of the research results.

Some pollutants are known to accumulate in the body's fatty tissue. How does this affect pregnant women? there a link between weight gain and the transfer of pollutants to the newborn? A new study provides new data that can help the administration and health managers in their decision making.

A research tested in zebrafish shows the potential of photopharmacology for future heart therapies more precise and with fewer side effects. The study is published in the journal Angewandte Chemie International Edition, selected as a Hot Paper.

The CSIC and the Miguel Hernández University have developed a robot and its software for counting and measuring, in an automated, precise and reliable way, the transition time between life stages of fruit flies and other insects.

The CSIC has developed, together with other institutions, a method to personalise therapeutic strategies combined with immune checkpoint inhibitors (ICIs) in cancer patients. It is based on 10 biomarkers, and facilitates the optimisation of therapeutic strategies for various types of tumours.

Researchers at IQAC-CSIC have successfully tested molecules that reverse the effect of the anticoagulant heparin, used to treat patients at risk of thrombosis. These new molecules have been patented. Patients treated with heparin may need to block its effect during surgery. The only drug available nowadays has a high molecular weight and may have associated side effects.

The use of electrical stimulation in medical research is growing rapidly for its effects on cell regeneration. The CSIC, the Autonomous University of Madrid and the University of Florida have developed a miniaturised device for in vitro electrical stimulation of cells and tissues. The technology is available for further development and commercialization.

Scientists from the CSIC, the University of Barcelona and the CIBER network laboratory have developed DNA probes for the fast detection of respiratory disease viruses, including SARS-CoV2 and influenza. The technology is available for further development through agreements with industry partners.